Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Desensitization in Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
- Status
- COMPLETED
- Phase
- PHASE2